Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37751 - 37775 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	MAATS1	89876	downregulated	entinostat results in decreased expression of MAATS1 mRNA	3q13.33	A21037
Entinostat	Investigational	MAB21L2	10586	downregulated	entinostat results in decreased expression of MAB21L2 mRNA	4q31.3	A21037
Entinostat	Investigational	MACC1	346389	upregulated	entinostat results in increased expression of MACC1 mRNA	7p21.1	A21037
Entinostat	Investigational	MACROD2	140733	downregulated	entinostat results in decreased expression of MACROD2 mRNA	20p12.1	A21037
Entinostat	Investigational	MADCAM1	8174	upregulated	entinostat results in increased expression of MADCAM1 mRNA	19p13.3	A21037
Entinostat	Investigational	MAF	4094	downregulated	entinostat results in decreased expression of MAF mRNA	16q23.2	A21037
Entinostat	Investigational	MAFB	9935	downregulated	entinostat results in decreased expression of MAFB mRNA	20q12	A21037
Entinostat	Investigational	MAGI2	9863	upregulated	entinostat results in increased expression of MAGI2 mRNA	7q21.11	A21037
Entinostat	Investigational	MAGI3	260425	downregulated	entinostat results in decreased expression of MAGI3 mRNA	1p13.2	A21037
Entinostat	Investigational	MAK	4117	downregulated	entinostat results in decreased expression of MAK mRNA	6p24.2	A21037
Entinostat	Investigational	MAL2	114569	upregulated	entinostat results in increased expression of MAL2 mRNA	8q24.12	A21037
Entinostat	Investigational	MALAT1	378938	upregulated	entinostat results in increased expression of MALAT1 mRNA	11q13.1	A21037
Entinostat	Investigational	MAMDC2	256691	downregulated	entinostat results in decreased expression of MAMDC2 mRNA	9q21.12	A21037
Entinostat	Investigational	MAML2	84441	downregulated	entinostat results in decreased expression of MAML2 mRNA	11q21	A21037
Entinostat	Investigational	MAN2A2	4122	downregulated	entinostat results in decreased expression of MAN2A2 mRNA	15q25	A21037
Entinostat	Investigational	MANSC1	54682	upregulated	entinostat results in increased expression of MANSC1 mRNA	12p13.2	A21035
Entinostat	Investigational	MAOA	4128	upregulated	entinostat results in increased expression of MAOA mRNA	Xp11.3	A21037 A21035
Entinostat	Investigational	MAP2K6	5608	downregulated	entinostat results in decreased expression of MAP2K6 mRNA	17q24.3	A21037
Entinostat	Investigational	MAP3K20	51776	downregulated	entinostat results in decreased expression of MAP3K20 mRNA	2q31.1	A21037
Entinostat	Investigational	MAP3K21	84451	upregulated	entinostat results in increased expression of MAP3K21 mRNA	1q42.2	A21037 A21035
Entinostat	Investigational	MAP3K5	4217	upregulated	entinostat results in increased expression of MAP3K5 mRNA	6q23.3	A21037
Entinostat	Investigational	MAP3K6	9064	upregulated	entinostat results in increased expression of MAP3K6 mRNA	1p36.11	A21035
Entinostat	Investigational	MAP3K8	1326	upregulated	entinostat results in increased expression of MAP3K8 mRNA	10p11.23	A21035
Entinostat	Investigational	MAP4K1	11184	upregulated	entinostat results in increased expression of MAP4K1 mRNA	19q13.1-q13.4	A21035
Entinostat	Investigational	MAPK10	5602	downregulated	entinostat results in decreased expression of MAPK10 mRNA	4q21.3	A21037

Displaying entries 37751 - 37775 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability